Orthopediatrics (KIDS) Cash & Equivalents (2015 - 2026)

Orthopediatrics' Cash & Equivalents history runs 12 years deep, the most recent figure standing at $12.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents fell 63.54% year-over-year to $12.2 million; the TTM figure through Mar 2026 stood at $12.2 million (down 63.54% YoY), while the FY2025 annual figure was $19.6 million, down 55.37% from the prior year.
• Cash & Equivalents was $12.2 million for Q1 2026 at Orthopediatrics, down from $19.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $51.0 million in Q3 2024 to a low of $9.0 million in Q4 2022.
• Historically, Cash & Equivalents has averaged $26.4 million across 5 years, with a median of $25.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 73.89% in 2023, then surged 379.77% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $9.0 million in 2022, then surged by 245.4% to $31.1 million in 2023, then jumped by 41.1% to $43.8 million in 2024, then tumbled by 55.37% to $19.6 million in 2025, then tumbled by 37.65% to $12.2 million in 2026.
• The last three Cash & Equivalents figures came in at $12.2 million (Q1 2026), $19.6 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.